Bolt Biotherapeutics (BOLT) Net Cash Flow (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Net Cash Flow of -$94000.0 for Q1 2026, up 98.45% sequentially from -$6.1 million in Q4 2025, and down 107.93% YoY from $1.2 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Net Cash Flow (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Net Cash Flow for 7 years, with the latest figure at -$94000.0 in Q1 2026.
- Quarterly Net Cash Flow fell 107.93% year-over-year to -$94000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 22.72% YoY) and the FY2025 annual result came in at $4.5 million, up 224.02% from the prior year.
- Net Cash Flow rose to -$94000.0 in Q1 2026 per BOLT's latest filing, from -$6.1 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $16.6 million in Q1 2022 and troughed at -$21.4 million in Q2 2022.
- A 5-year average of -$926352.9 and a median of -$94000.0 in 2026 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 226.63% in 2024, down 231.45% in 2024.
- Over 5 years, Net Cash Flow stood at -$1.4 million in 2022, then surged by 220.17% to $1.6 million in 2023, then plunged by 231.45% to -$2.2 million in 2024, then plunged by 180.18% to -$6.1 million in 2025, then jumped by 98.45% to -$94000.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$94000.0, -$6.1 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -496,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.14 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Mn |
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | -94,000.00 |
| Mar 31, 2026 | -94,000.00 |
| Dec 31, 2025 | -6.08 Mn |
| Dec 31, 2025 | -6.08 Mn |
| Sep 30, 2025 | 8.15 Mn |
| Sep 30, 2025 | 8.15 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | -6.55 Mn |
| Mar 31, 2024 | -6.55 Mn |